A computational protein engineering platform for discovering and enhancing thermostable enzymes capable of degrading biodegradable plastics (PLA and PHA). By combining bioinformatic genome mining with structure-based design tools, the approach targets enzymes that operate at optimal degradation temperatures (~58°C), enabling more efficient polymer hydrolysis for chemical upcycling.
This research addresses a critical bottleneck in enzymatic plastic recycling: most known polymer-degrading enzymes are mesophilic, meaning they operate only between 20–45°C, which is well below the optimal temperature range (~58°C) for efficient hydrolysis of biodegradable plastics such as polylactic acid (PLA) and polyhydroxyalkanoates (PHA). The project pursues a dual strategy of (1) bioinformatic genome mining to identify novel depolymerases from the α/β hydrolase enzyme family based on sequence and structural similarity to known PLA/PHA-degrading enzymes, and (2) computational protein engineering to enhance the thermostability of these candidates. The ultimate goal is to produce engineered enzymes that perform at higher temperatures, accelerating polymer breakdown into monomers or smaller subunits that can be recovered and reused through chemical upcycling.
Discovery approach:
Engineering approach:
Prior studies using similar combinatorial strategies have achieved melting temperature improvements of up to 30°C in related hydrolases, demonstrating feasibility of the approach.
The project is at an early-to-mid stage of development. The discovery and engineering workflows draw on validated computational tools (PROSS, Rosetta, AlphaFold2) that have demonstrated success in improving thermostability of related enzymes such as PETase, cutinase, and lipases. Future validation will proceed through gene synthesis, expression, purification, activity screening, and iterative engineering cycles. The approach is currently focused on laboratory validation; scaling to industrial bioprocessing conditions has not yet been addressed.
UC Davis is a comprehensive public research university in Northern California, combining a land-grant heritage with an integrated academic health system and a veterinary teaching hospital. Industry engages through co-located clinical and translational facilities in Sacramento, a campus-adjacent research park, pilot-scale food and bioprocessing facilities, and a statewide extension network for field-to-market deployment. Proximity to the Bay Area and California's Central Valley enables rapid collaboration with startups and established enterprises, while corporate relations staff streamline access to faculty, talent, and core labs. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office and venture support programs provide IP management, licensing, and startup formation pathways for industry partnerships.